eGenesis
Latest round
- Series D
Last raised
- Sep 2024
Total raised
- $429M
Investors
- 29
About eGenesis
Founded in 2015 and headquartered in Cambridge, US, eGenesis, Inc. focuses on developing xenotransplantation solutions.eGenesis is a biotechnology company focused on revolutionizing organ and cell transplantation through its innovative multiplex gene editing and genome engineering platform. The company's flagship offerings include the development of Human Compatible (HuCo™) organs and cells, particularly targeting xenotransplantation solutions for kidney and islet cells. These products aim to address the critical shortage of transplantable organs, improving patient outcomes and extending quality of life for individuals with serious organ failures. eGenesis's technologies leverage the latest advancements in gene editing to create organs compatible with human biology, expanding the potential donor pool and reducing wait times for traditional organ transplants.eGenesis generates revenue through strategic partnerships and collaborations within the healthcare industry, focusing on B2B transactions with healthcare providers and research institutions.In September 2024, eGenesis, Inc. The company aims to expand its market presence by targeting international regions experiencing severe organ shortages, although specific markets and timelines for this expansion have yet to be detailed.
Who invested in eGenesis
29 investors across 4 rounds
See all investors in eGenesis
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about eGenesis
Who invested in eGenesis?
eGenesis has 29 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has eGenesis raised?
eGenesis has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did eGenesis last raise money?
eGenesis's most recent round on record is a Series D, in Sep 2024.
What does eGenesis do?
Founded in 2015 and headquartered in Cambridge, US, eGenesis, Inc.
Where is eGenesis headquartered?
eGenesis is headquartered in Cambridge, US.
Which VCs invest in companies like eGenesis?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at eGenesis's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like eGenesis? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.